Integrated Investment Consultants’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,123
| Closed | -$251K | – | 253 |
|
|
2022
Q1 | $251K | Buy |
6,123
+151
| +3% | +$6.19K | 0.07% | 248 |
|
|
2021
Q4 | $260K | Sell |
5,972
-7
| -0.1% | -$305 | 0.07% | 253 |
|
|
2021
Q3 | $299K | Buy |
5,979
+64
| +1% | +$3.2K | 0.09% | 212 |
|
|
2021
Q2 | $373K | Buy |
5,915
+2,182
| +58% | +$138K | 0.11% | 169 |
|
|
2021
Q1 | $347K | Buy |
3,733
+197
| +6% | +$18.3K | 0.12% | 169 |
|
|
2020
Q4 | $317K | Buy |
3,536
+17
| +0.5% | +$1.52K | 0.12% | 157 |
|
|
2020
Q3 | $364K | Buy |
+3,519
| New | +$364K | 0.17% | 109 |
|
|
2020
Q2 | – | Sell |
-3,615
| Closed | -$209K | – | 171 |
|
|
2020
Q1 | $209K | Buy |
+3,615
| New | +$209K | 0.12% | 128 |
|